Close Menu
Home › Resources › Genomics: Clinical Implementation

Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests. 

Multi-Gene Panel Testing Moderately Cost Effective for Lung Cancer Patients

Premium

A Personalized Medicine Coalition-funded study has found that NGS-based testing is moderately cost effective but that access to targeted treatments remains a hurdle. 

Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

Premium

Presentations at this month's ASCO meeting demonstrated how efforts are advancing to determine when and how longitudinal ctDNA testing will be useful for oncologists.

Cascade Testing for Dilated Cardiomyopathy Likely to Be Cost Effective, Analysis Finds

An Australian team developed a decision model for testing asymptomatic relatives of patients with dilated cardiomyopathy to assess the cost effectiveness of testing.

AMP and CAP Comment on Palmetto Proposed Guidelines for NGS Testing of Myeloid Disorders

The organizations provided a list of genes they believe are informative in treatment of myeloid disorders and suggested several changes to the coverage policy.

Clinical PGx Consortium Taking Aim at Non-Actionable Genes, Countering 'Inappropriate' Marketing

Premium

CPIC wants to issue guidelines for non-actionable genes, standardize PGx terms, and work with groups like ClinGen and ClinVar to expand use of its guidelines.

Jun 10, 2019

AMP Updates Position Statement on DTC Genomic Testing

May 24, 2019

Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays

Premium
May 08, 2019

BillionToOne to Launch Noninvasive Prenatal Screening Test; Plans Liquid Biopsy Products

Premium
May 03, 2019

Helix Eyeing Partnerships With Health Systems on Large Population Health Studies

Premium
May 01, 2019

CMS Reopens National Coverage Determination for NGS Testing in Advanced Cancer

Apr 26, 2019

Inivata Clinical Validation Bolsters Liquid Biopsy Evidence Base, Aids Platform Comparisons

Premium
Apr 24, 2019

Rady Team Automates Rapid Pediatric Sequence Interpretation for Rare Disease Dx

Apr 23, 2019

Illumina, Chinese Children's Hospital to Launch Newborn Sequencing Study

Apr 23, 2019

Veracyte Secures NY State Approval for Genomic Classifier Test for Lung Disease

Apr 11, 2019

FH Foundation, Invitae, Genome Medical Partner on Genetic Testing Initiative

Apr 09, 2019

Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies

Premium
Apr 08, 2019

Expanded Germline Panel Testing in Cancer Patients Catches Risk Variants Missed by Focused Tests

Apr 05, 2019

UK Hospital Launches Nanopore Sequencing Huntington's Dx as Reflex Test

Premium
Apr 04, 2019

High-Resolution HLA Genotyping Improves Matching, Survival Rates for Stem Cell Transplantation

Premium
Apr 04, 2019

Memorial Sloan Kettering Nears Approval for Liquid Biopsy Test; Describes Validation at AACR

Premium
Apr 03, 2019

NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education

Apr 03, 2019

Resolution Bio Liquid Biopsy Outperforms Guardant Test in Lung Cancer Gene Fusion Detection

Premium
Apr 02, 2019

AACR Liquid Biopsy Studies Demonstrate Diversity of Methods for Early Cancer Detection

Premium
Apr 02, 2019

Veracyte Genomic Classifier Test for Lung Disease Validated in Clinical Study

Apr 01, 2019

Guardant Health AACR Data Hint at Future Potential of Bellwether Acquisition

Premium
More articles

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.